Clinical Trials
30 trialsA Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis
Guangdong Hengrui Pharmaceutical Co., Ltd
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
Alexion Pharmaceuticals, Inc.
ArchAid-002
Beijing GoBroad Hospital
REAL MG PRO
Centre Hospitalier Universitaire de Nice
TAILOR-MG
IRCCS San Raffaele
Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
Shenzhen MagicRNA Biotechnology Co., Ltd
Talquetamab in Patients With Refractory Generalized Myasthenia Gravis
First Affiliated Hospital of Chongqing Medical University
MY-EDUC
University Hospital, Grenoble
MyVision
UCB Pharma
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
UCB Pharma
A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis
The Children's Hospital of Zhejiang University School of Medicine
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Detecting Fatigue From Voice in Generalised Myasthenia Gravis
Thymia Limited
RIPERT-MG
Xinqiao Hospital of Chongqing
Tongji NADs Cohort
Tongji Hospital
PROMPT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
HARMONY 360
Ad scientiam
Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
Guangdong ProCapZoom Biosciences Co., Ltd.
BioDigit MG-03
BioSensics
BioDigit MG-02
BioSensics
APART-MG
Universite du Littoral Cote d'Opale
Efgartigimod for Consolidation Therapy in gMG
Da, Yuwei, M.D.
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
Changzhou No.2 People's Hospital
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
Zhejiang University
Blinatumomab for Treatment of Refractory Myasthenia Gravis
Da, Yuwei, M.D.
Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis
First Affiliated Hospital of Wenzhou Medical University
KY2024-853
Huashan Hospital
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
Xuanwu Hospital, Beijing
Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
First Affiliated Hospital of Wenzhou Medical University
Perioperative Efgartigimod for Thymoma and Myasthenia Gravis
Shanghai Zhongshan Hospital